Investing.com - Biogen (NASDAQ:BIIB) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Biogen announced earnings per share of $5.34 on revenue of $2.69B. Analysts polled by Investing.com anticipated EPS of $5.02 on revenue of $2.66B.
Biogen shares are up 10% from the beginning of the year and are trading at $269.85 , down-from-52-week-high.They are outperforming the Nasdaq which is up 8.24% from the start of the year.
Biogen follows other major Healthcare sector earnings this month
Biogen's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.33 on revenue of $22.01B.
Abbott Labs had beat expectations on Tuesday with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar